Duhring Brocq Disease: The First Manifestation of Celiac Disease in an Adolescent

Mircea Mărgescu^1, , Camelia Carmen Mărgescu¹, Anca Cioclea¹, Raluca Șandor¹ and Iulian Valasciuc²

¹Pediatric Clinic II, Emergency Hospital for Children, Cluj-Napoca, Romania

²Municipal Hospital Radauti, Romania

Cite this paper:
Mircea Mărgescu, Camelia Carmen Mărgescu, Anca Cioclea, Raluca Șandor and Iulian Valasciuc. Duhring Brocq Disease: The First Manifestation of Celiac Disease in an Adolescent. International Journal of Celiac Disease. 2016; 4(4):150-153. doi: 10.12691/ijcd-4-4-8

Abstract

Dermatitis herpetiformis (Duhring Brocq disease) is an autoimmune inflammatory disease determining polymoprhic pruriginous lesions. It is always associated with a gluten sensitive enteropathy which is most frequently clinically silent. The diagnosis is made on the basis of clinical, serological (IgA antitransglutaminase antibodies and antiendomysial antibodies), hystological and immunollogical (granular immunglobulin A deposits in the papilarry dermis by direct immunofluorescence) data. We present the case of an adolescent with dermatitis herpetiformis associated with atypical celiac disease. The particularity of the case was the abscence of other celiac disease manifestations and the finding of a cutaneous abscess infected with Staphiloccocus aureus, facilitated by the excoriated lesions caused by scratching, which was afterwards complicated with septic arthritis. After 6 weeks of gluten-free diet the cutaneous lesions dissapeared and the pruritus diminished.

Keywords:
dermatitis herpetiformis celiac disease gluten-free-diet

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Karpati, S, Dermatitis herpetiformis: close to unveiling a disease, J Dermatol Sci. 34 83-90. 2004.
[2]	Caproni, M, Antiga, E, Melani Fabbri, P, Guidelines for the diagnosis and treatment of dermatitis herpetiformis, J Eur Acad Dermatol Venereol, 23(6). 633-638. Jan. 2008.
[3]	Băican, A, Băican, C, Maier, N. Dermatita herpetiformă-mecanisme patogenetice, diagnostic și tratament, Rev Dermato Venerol, Bucharest, 55. 35-42. 2009.
[4]	Coman, O.A, Ungureanu, A.M, Rusu, A et al, Dermatita herpetiformă Duhring-Brocq: aspecte clinice, fiziopatologice și terapeutice, Dermato Venerol, 58. 59-68. 2013.
[5]	Stănescu Popp, A, Diagnostic în boala celiacă la copil, Editura, București, 2006, 42-44.
[6]	Reunala, T, Incidence of familial dermatitis herpetiformis, Br J Dermatol, 134. 394-398. 1996.
[7]	Megiorni, F, Pizzuti, A, HLA-DQA1 and HLA-DQB1 în celiac disease predisposition: practical implications of the molecular typing, J Biomed Science. 19-88. 2002.
[8]	Sardy M, Karpati S, Merkl B et al. Epidermal TGL is the autoantigen of dermatitis herpetiformis . J Exp Med, Vol. 195. 747-757. 2002.
[9]	Kumar, V, Jarzabek-Chorzelska, M, Sulej, J et al, Tissue transglutaminase and endomysial antibodies – diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis, Int J Dermatol, 98. 378-382. 2007.
[10]	Beutner EH, Plemkett RW, Methods for diagnosing dermatitis herpetiformis J Am Acad Dermatol 2006; 55: 1112-3
[11]	Marzari, R, Sblattero, D, Florian, F et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease, J Immunol, 166. 4170-4176. 2001.
[12]	Doffoel-Hantz V., Cogne M, Sparsa, A et al. Physiopathologie de la dermatite herpetiforme. Donnes actuelles. Ann Dermato Venerol, 1350. 784-788. 2008.
[13]	Hull, CM, Liddle, M, Hansen, N, Meyer, LJ, Schmidt, L et al, Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis, Br J Dermatol, 159. 120-124. 2008.